Xu Zhenxing, Su Chang, Xiao Yunyu, Wang Fei
Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York 10065, United States.
Department of Health Service Administration and Policy, Temple University, Philadelphia 19122, United States.
Intell Med. 2022 Feb;2(1):13-29. doi: 10.1016/j.imed.2021.09.001. Epub 2021 Oct 21.
The new coronavirus disease 2019 (COVID-19) has become a global pandemic leading to over 180 million confirmed cases and nearly 4 million deaths until June 2021, according to the World Health Organization. Since the initial report in December 2019 , COVID-19 has demonstrated a high transmission rate (with an R > 2), a diverse set of clinical characteristics (e.g., high rate of hospital and intensive care unit admission rates, multi-organ dysfunction for critically ill patients due to hyperinflammation, thrombosis, etc.), and a tremendous burden on health care systems around the world. To understand the serious and complex diseases and develop effective control, treatment, and prevention strategies, researchers from different disciplines have been making significant efforts from different aspects including epidemiology and public health, biology and genomic medicine, as well as clinical care and patient management. In recent years, artificial intelligence (AI) has been introduced into the healthcare field to aid clinical decision-making for disease diagnosis and treatment such as detecting cancer based on medical images, and has achieved superior performance in multiple data-rich application scenarios. In the COVID-19 pandemic, AI techniques have also been used as a powerful tool to overcome the complex diseases. In this context, the goal of this study is to review existing studies on applications of AI techniques in combating the COVID-19 pandemic. Specifically, these efforts can be grouped into the fields of epidemiology, therapeutics, clinical research, social and behavioral studies and are summarized. Potential challenges, directions, and open questions are discussed accordingly, which may provide new insights into addressing the COVID-19 pandemic and would be helpful for researchers to explore more related topics in the post-pandemic era.
据世界卫生组织统计,截至2021年6月,新型冠状病毒肺炎(COVID-19)已成为全球大流行疾病,确诊病例超过1.8亿例,死亡病例近400万例。自2019年12月首次报告以来,COVID-19已显示出高传播率(R>2)、多样的临床特征(例如,高住院率和重症监护病房入住率,重症患者因炎症反应过度、血栓形成等导致多器官功能障碍),并给世界各地的医疗系统带来了巨大负担。为了了解这种严重而复杂的疾病并制定有效的控制、治疗和预防策略,来自不同学科的研究人员一直在从流行病学和公共卫生、生物学和基因组医学以及临床护理和患者管理等不同方面做出重大努力。近年来,人工智能(AI)已被引入医疗保健领域,以辅助疾病诊断和治疗的临床决策,如基于医学图像检测癌症,并在多个数据丰富的应用场景中取得了卓越的性能。在COVID-19大流行中,AI技术也被用作战胜这种复杂疾病的有力工具。在此背景下,本研究的目的是回顾关于AI技术在抗击COVID-19大流行中应用的现有研究。具体而言,这些努力可分为流行病学、治疗学、临床研究、社会和行为研究领域,并进行了总结。相应地讨论了潜在的挑战、方向和开放性问题,这可能为应对COVID-19大流行提供新的见解,并有助于研究人员在大流行后时代探索更多相关主题。